A double-blind study to determine the maximum tolerated dose of ethionamide, when administered twice-weekly to patients with pulmonary tuberculosis.
D000367:Age Factors; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D001835:Body Weight; D002986:Clinical Trials as Topic; D005000:Ethionamide / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D012737:Sex Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000636:Aminosalicylic Acids; D005000:Ethionamide